Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

According to Research by SNS Insider, Organ-on-a-Chip Market growth is driven by advancements in biotechnology, increasing demand for drug testing alternatives, and rising investments in organ ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to discover new molecules and potential therapies. Pfizer is partnering with ...

Flagship Pioneering-backed Sail Biomedicines has laid off 12 employees following a review of the company’s organizational ...

Pfizer and Flagship Pioneering are turning to autoimmune disease as the sixth plank of their multibillion-dollar, 10-program ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...

There are plenty of different alternatives for anyone looking to add a skin serum to their routine. At Superdrug, there's the ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.